Last reviewed · How we verify
NCT07206082: LUDICO
Coronary Laser in Undilatable or Uncrossable Lesions
trial testing Laser atherectomy in Coronary Artery Disease in 230 participants. Participants enrolled and being followed up; not accepting new ones.
10 March 2025
Quick facts
| Lead sponsor | Hospital Universitario La Paz |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 230 |
| Start date | 5 June 2020 |
| Primary completion | 10 March 2025 |
| Estimated completion | 20 October 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Laser atherectomy
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Calcified Coronary Artery Disease — all drugs for Calcified Coronary Artery Disease →
- In Stent Restenosis — all drugs for In Stent Restenosis →
- Chronic Total Occlusion (CTO) — all drugs for Chronic Total Occlusion (CTO) →
Sponsor
Hospital Universitario La Paz
Who can join
18 and older, any sex, with Coronary Artery Disease or Calcified Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This will be an investigator-initiated, multicentre, single-arm, open-label, prospective observational study. Patients with indication for PCI and undilatable (non-compliant balloon dilatation \<80% at burst pressure) or uncrossable (not crossable with a "small-profile balloon" with adequate support, according to operator´s discretion) coronary lesions treated with ELCA will be included. Intravascular imaging will be highly recommendable and analysed in a central core-laboratory. Device success, angiographical success, procedural success, clinical success and related complications will be evaluated. Patients will be followed for 1 year after the procedure and clinical events will be recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07206082
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Hospital Universitario La Paz trials
Trials by the same sponsor.
- NCT07479927 — Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Alloge · NA · recruiting
- NCT07260643 — SiLaC Laser Technique for Pilonidal Sinus - La Paz Cohort Study. · not yet recruiting
- NCT07203664 — Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prop · Phase 4 · not yet recruiting
- NCT07023601 — International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First · NA · enrolling by invitation
- NCT03086850 — Long-term Effect of the Physical Activity Promotion on the Clinical Characteristics and Vascular Risk in Patients With M · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07206082 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario La Paz
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07206082.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing